Semiquantitative optic nerve grading scheme for determining axonal loss in experimental optic neuropathy

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 2, 2006, Pages 634-640

  Chauhan, Balwantray C ^a,b   LeVatte, Terry L ^a,b   Garnier, Krista L ^b   Tremblay, François ^a,b   Pang, Iok Hou ^c   Clark, Abbot F ^c   Archibald, Michele L ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONFIDENCE INTERVAL; CONTROLLED STUDY; MALE; MICROSCOPY; NERVE FIBER MEMBRANE; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; OSMOTIC MINIPUMP; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SURVIVAL; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BROWN NORWAY RAT; CELL SURVIVAL; CHRONIC DISEASE; CLASSIFICATION; DISEASE MODEL; DRUG EFFECT; NERVE FIBER; OBSERVER VARIATION; PATHOLOGY; RETINA GANGLION CELL;

ENDOTHELIN 1;

ANIMALS; AXONS; CELL COUNT; CELL SURVIVAL; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; MALE; OBSERVER VARIATION; OPTIC NERVE; OPTIC NERVE DISEASES; RATS; RATS, INBRED BN; RETINAL GANGLION CELLS;

EID: 33644849135     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1206     Document Type: Article

References (28)

1. Morrison JC, Nylander KB, Lauer AK, Cepurna WO, Johnson E. Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma. Invest Ophthalmol Vis Sci. 1998;39:526-531.
2. Chaudhary P, Ahmed F, Sharma SC. MK801-a neuroprotectant in rat hypertensive eyes. Brain Res. 1998;792:154-158.
3. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA. 1999;96:9944-9948.
4. Yoles E, Wheeler LA, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 1999;40:65-73.
5. Schori H, Kipnis J, Yoles E, et al. Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci USA. 2001;98:3398-3403.
6. WoldeMussie E, Yoles E, Schwartz M, Ruiz G, Wheeler LA. Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma. 2002;11:474-480.
7. McKinnon SJ, Lehman DM, Tahzib NG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther. 2002;5:780-787.
8. Martin KR, Quigley HA, Zack DJ, et al. Gene therapy with brainderived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2003;44:4357-4365.
9. Zhou Y, Pernet V, Hauswirth WW, Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol Ther. 2005;12:402-412.
10. Vidal-Sanz M, Bray GM, Villegas-Perez MP, Thanos S, Aguayo AJ. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci. 1987;7:2894-2909.
11. Thanos S, Kacza J, Seeger J, Mey J. Old dyes for new scopes: the phagocytosis-dependent long-term fluorescence labelling of microglial cells in vivo. Trends Neurosci. 1994;17:177-182.
12. Selles-Navarro I, Villegas-Perez MP, Salvador-Silva M, Ruiz-Gomez JM, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals: a quantitative in vivo study. Invest Ophthalmol Vis Sci. 1996;37:2002-2014.
13. Danias J, Shen F, Goldblum D, et al. Cytoarchitecture of the retinal ganglion cells in the rat. Invest Ophthalmol Vis Sci. 2002;43:587-594.
14. Kobbert C, Apps R, Bechmann I, et al. Current concepts in neuroanatomical tracing. Prog Neurobiol. 2000;62:327-351.
15. Mittag TW, Danias J, Pohorenec G, et al. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2000;41:3451-3459.
16. Libby RT, Li Y, Savinova OV, et al. Susceptibility to neurodegeneration in a glaucoma is modified by bax gene dosage. PLoS Genet. 2005;1:E4.
17. Balazsi AG, Rootman J, Drance SM, Schulzer M, Douglas GR. The effect of age on the nerve fiber population of the human optic nerve. Am J Ophthalmol. 1984;97:760-766.
18. Quigley HA, Sanchez RM, Dunkelberger GR, L'Hernault NL, Baginski TA. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci. 1987;28:913-920.
19. Jonas JB, Muller-Bergh JA, Schlotzer-Schrehardt UM, Naumann GO. Histomorphometry of the human optic nerve. Invest Ophthalmol Vis Sci. 1990;31:736-744.
20. Mikelberg FS, Yidegiligne HM, White VA, Schulzer M. Relation between optic nerve axon number and axon diameter to scleral canal area. Ophthalmology. 1991;98:60-63.
21. Jia L, Cepurna WO, Johnson EC, Morrison JC. Patterns of intraocular pressure elevation after aqueous humor outflow obstruction in rats. Invest Ophthalmol Vis Sci. 2000;41:1380-1385.
22. Levkovitch-Verbin H, Martin KR, Quigley HA, et al. Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transsection. J Glaucoma. 2002;11:396-405.
23. Morrison JC, Johnson EC, Cepurna W, Jia L. Understanding mechanisms of pressure-induced optic nerve damage. Prog Retin Eye Res. 2005;24:217-240.
24. Chauhan BC, LeVatte TL, Jollimore CA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144-152.
25. Hollander H, Vaaland JL. A reliable staining method for semi-thin sections in experimental neuroanatomy. Brain Res. 1968;10:120-126.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
27. Chauhan BC, Pan J, Archibald ML, et al. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest Ophthalmol Vis Sci. 2002;43:2969-2976.
28. Cull G, Cioffi GA, Dong J, Homer L, Wang L. Estimating normal optic nerve axon numbers in non-human primate eyes. J Glaucoma. 2003;12:301-306.